title: Diabetic retinopathy: targeting vasoregression.
authors.affiliation: University of Heidelberg, Mannheim, Germany. hans-peter.hammes@med5.ma.uni-heidelberg.de
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Hammes
authors.forename: Yuxi
authors.initials: Y
authors.lastname: Feng
authors.forename: Frederick
authors.initials: F
authors.lastname: Pfister
authors.forename: Michael
authors.initials: M
authors.lastname: Brownlee
mesh_terms: D042683:Angiopoietin-1 / Q000502:physiology; D000818:Animals; D002465:Cell Movement; D003930:Diabetic Retinopathy / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D004921:Erythropoietin / Q000502:physiology*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D007249:Inflammation / Q000503:physiopathology; D051379:Mice; D008822:Mice, Transgenic; D009389:Neovascularization, Pathologic / Q000473:pathology; D018919:Neovascularization, Physiologic; D042787:Receptor, TIE-2 / Q000502:physiology; D012160:Retina / Q000473:pathology / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
chemical_list: D042683:Angiopoietin-1; D042461:Vascular Endothelial Growth Factor A; D004921:Erythropoietin; D042787:Receptor, TIE-2